by Anne Crawford
While treatments are becoming increasingly effective in countering many of the symptoms of multiple sclerosis (MS), linking actual changes in the brain to its more elusive symptoms is vital to driving the development of therapies that can ultimately halt the disease.
Monash University researchers, led by Associate Professor Joanne Fielding and Dr Meaghan Clough in the Department of Neuroscience, are investigating deficits in executive control, that is the way our ‘higher brain’ controls basic behaviour, and determining which area in the brain is driving these deficits.
While treatments are becoming increasingly effective in countering many of the symptoms of multiple sclerosis (MS), linking actual changes in the brain to its more elusive symptoms is vital to driving the development of therapies that can ultimately halt the disease.
Monash University researchers, led by Associate Professor Joanne Fielding and Dr Meaghan Clough in the Department of Neuroscience, are investigating deficits in executive control, that is the way our ‘higher brain’ controls basic behaviour, and determining which area in the brain is driving these deficits.